The Novel Protease-Activated Receptor 1 Antagonist Vorapaxar as a Treatment for Thrombosis in Afibrinogenemia

Bernard Tawfik, Elizabeth Pollard, Yu Min Shen

Research output: Contribution to journalLetter

3 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)404-406
Number of pages3
JournalSeminars in Thrombosis and Hemostasis
Volume44
Issue number4
DOIs
StatePublished - Jun 1 2018

Fingerprint

Afibrinogenemia
PAR-1 Receptor
Thrombosis
vorapaxar

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine

Cite this

The Novel Protease-Activated Receptor 1 Antagonist Vorapaxar as a Treatment for Thrombosis in Afibrinogenemia. / Tawfik, Bernard; Pollard, Elizabeth; Shen, Yu Min.

In: Seminars in Thrombosis and Hemostasis, Vol. 44, No. 4, 01.06.2018, p. 404-406.

Research output: Contribution to journalLetter

@article{33f1dc1ccc5a4c75b1de48cb7ef0762a,
title = "The Novel Protease-Activated Receptor 1 Antagonist Vorapaxar as a Treatment for Thrombosis in Afibrinogenemia",
author = "Bernard Tawfik and Elizabeth Pollard and Shen, {Yu Min}",
year = "2018",
month = "6",
day = "1",
doi = "10.1055/s-0038-1654715",
language = "English (US)",
volume = "44",
pages = "404--406",
journal = "Seminars in Thrombosis and Hemostasis",
issn = "0094-6176",
publisher = "Thieme Medical Publishers",
number = "4",

}

TY - JOUR

T1 - The Novel Protease-Activated Receptor 1 Antagonist Vorapaxar as a Treatment for Thrombosis in Afibrinogenemia

AU - Tawfik, Bernard

AU - Pollard, Elizabeth

AU - Shen, Yu Min

PY - 2018/6/1

Y1 - 2018/6/1

UR - http://www.scopus.com/inward/record.url?scp=85047161803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047161803&partnerID=8YFLogxK

U2 - 10.1055/s-0038-1654715

DO - 10.1055/s-0038-1654715

M3 - Letter

C2 - 29763961

AN - SCOPUS:85047161803

VL - 44

SP - 404

EP - 406

JO - Seminars in Thrombosis and Hemostasis

JF - Seminars in Thrombosis and Hemostasis

SN - 0094-6176

IS - 4

ER -